Istiklal Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Crohn's disease1 trial
• Multiple sclerosis1 trial
• Sickle cell disease1 trial
• Spinal cord injury1 trial
• Ulcerative colitis1 trial

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Cristcot HCA LLC1 trial
• Immunic AG1 trial
• Janssen Research & Development, LLC1 trial
• Novo Nordisk A/S1 trial
• Urovant Sciences GmbH1 trial

Running trials

• Recruiting

  Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

  NCT05491525· Phase 2/3· Urovant Sciences GmbH· Source

  Contact: Mohammad Al-Zubi (principal investigator)

• Active, not recruiting

  A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

  NCT05197049· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

  NCT05134441· Phase 3· Immunic AG· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Spinal cord injury1 recruiting

Closed trials

• Completed

  Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

  NCT05405114· Phase 2· Novo Nordisk A/S· Source

• Completed

  Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

  NCT04469686· Phase 3· Cristcot HCA LLC· Source